nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—CYP2A6—Prednisolone—psoriatic arthritis	0.264	0.383	CbGbCtD
Arformoterol—CYP2A6—Dexamethasone—psoriatic arthritis	0.156	0.226	CbGbCtD
Arformoterol—CYP2C19—Prednisone—psoriatic arthritis	0.103	0.15	CbGbCtD
Arformoterol—CYP2C19—Dexamethasone—psoriatic arthritis	0.0644	0.0934	CbGbCtD
Arformoterol—CYP2C9—Dexamethasone—psoriatic arthritis	0.0535	0.0776	CbGbCtD
Arformoterol—CYP2D6—Dexamethasone—psoriatic arthritis	0.0489	0.071	CbGbCtD
Arformoterol—Hyperglycaemia—Prednisone—psoriatic arthritis	0.000691	0.00222	CcSEcCtD
Arformoterol—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.000681	0.00219	CcSEcCtD
Arformoterol—Visual impairment—Dexamethasone—psoriatic arthritis	0.000678	0.00218	CcSEcCtD
Arformoterol—Visual impairment—Betamethasone—psoriatic arthritis	0.000678	0.00218	CcSEcCtD
Arformoterol—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000678	0.00218	CcSEcCtD
Arformoterol—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000674	0.00217	CcSEcCtD
Arformoterol—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.000673	0.00217	CcSEcCtD
Arformoterol—Angioedema—Prednisolone—psoriatic arthritis	0.000671	0.00216	CcSEcCtD
Arformoterol—Myocardial infarction—Prednisone—psoriatic arthritis	0.000669	0.00216	CcSEcCtD
Arformoterol—Malaise—Prednisolone—psoriatic arthritis	0.000662	0.00213	CcSEcCtD
Arformoterol—Dysgeusia—Triamcinolone—psoriatic arthritis	0.000661	0.00213	CcSEcCtD
Arformoterol—Back pain—Triamcinolone—psoriatic arthritis	0.000653	0.0021	CcSEcCtD
Arformoterol—Asthma—Methotrexate—psoriatic arthritis	0.00064	0.00206	CcSEcCtD
Arformoterol—Hypertension—Prednisolone—psoriatic arthritis	0.000634	0.00204	CcSEcCtD
Arformoterol—Arrhythmia—Dexamethasone—psoriatic arthritis	0.000629	0.00202	CcSEcCtD
Arformoterol—Arrhythmia—Betamethasone—psoriatic arthritis	0.000629	0.00202	CcSEcCtD
Arformoterol—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000627	0.00202	CcSEcCtD
Arformoterol—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000625	0.00201	CcSEcCtD
Arformoterol—Discomfort—Prednisolone—psoriatic arthritis	0.000618	0.00199	CcSEcCtD
Arformoterol—Angioedema—Triamcinolone—psoriatic arthritis	0.000617	0.00199	CcSEcCtD
Arformoterol—Angioedema—Methylprednisolone—psoriatic arthritis	0.000616	0.00198	CcSEcCtD
Arformoterol—Malaise—Triamcinolone—psoriatic arthritis	0.000609	0.00196	CcSEcCtD
Arformoterol—Malaise—Methylprednisolone—psoriatic arthritis	0.000608	0.00196	CcSEcCtD
Arformoterol—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000602	0.00194	CcSEcCtD
Arformoterol—Oedema—Prednisolone—psoriatic arthritis	0.000599	0.00193	CcSEcCtD
Arformoterol—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000599	0.00193	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000595	0.00192	CcSEcCtD
Arformoterol—Cough—Triamcinolone—psoriatic arthritis	0.000589	0.0019	CcSEcCtD
Arformoterol—Tachycardia—Prednisolone—psoriatic arthritis	0.000585	0.00188	CcSEcCtD
Arformoterol—Hypertension—Triamcinolone—psoriatic arthritis	0.000583	0.00188	CcSEcCtD
Arformoterol—Hypertension—Methylprednisolone—psoriatic arthritis	0.000582	0.00187	CcSEcCtD
Arformoterol—Myalgia—Triamcinolone—psoriatic arthritis	0.000575	0.00185	CcSEcCtD
Arformoterol—Myalgia—Methylprednisolone—psoriatic arthritis	0.000574	0.00185	CcSEcCtD
Arformoterol—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000574	0.00185	CcSEcCtD
Arformoterol—Anxiety—Methylprednisolone—psoriatic arthritis	0.000572	0.00184	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00057	0.00183	CcSEcCtD
Arformoterol—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000569	0.00183	CcSEcCtD
Arformoterol—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000569	0.00183	CcSEcCtD
Arformoterol—Discomfort—Triamcinolone—psoriatic arthritis	0.000568	0.00183	CcSEcCtD
Arformoterol—Discomfort—Methylprednisolone—psoriatic arthritis	0.000567	0.00182	CcSEcCtD
Arformoterol—Dry mouth—Triamcinolone—psoriatic arthritis	0.000562	0.00181	CcSEcCtD
Arformoterol—Angioedema—Betamethasone—psoriatic arthritis	0.00056	0.0018	CcSEcCtD
Arformoterol—Angioedema—Dexamethasone—psoriatic arthritis	0.00056	0.0018	CcSEcCtD
Arformoterol—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000555	0.00179	CcSEcCtD
Arformoterol—Immune system disorder—Prednisone—psoriatic arthritis	0.000554	0.00178	CcSEcCtD
Arformoterol—Malaise—Betamethasone—psoriatic arthritis	0.000553	0.00178	CcSEcCtD
Arformoterol—Malaise—Dexamethasone—psoriatic arthritis	0.000553	0.00178	CcSEcCtD
Arformoterol—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000551	0.00177	CcSEcCtD
Arformoterol—Oedema—Triamcinolone—psoriatic arthritis	0.000551	0.00177	CcSEcCtD
Arformoterol—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00055	0.00177	CcSEcCtD
Arformoterol—Arrhythmia—Prednisone—psoriatic arthritis	0.000548	0.00176	CcSEcCtD
Arformoterol—Infection—Triamcinolone—psoriatic arthritis	0.000548	0.00176	CcSEcCtD
Arformoterol—Infection—Methylprednisolone—psoriatic arthritis	0.000546	0.00176	CcSEcCtD
Arformoterol—Haematuria—Methotrexate—psoriatic arthritis	0.000544	0.00175	CcSEcCtD
Arformoterol—Insomnia—Prednisolone—psoriatic arthritis	0.000542	0.00175	CcSEcCtD
Arformoterol—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000539	0.00174	CcSEcCtD
Arformoterol—Tachycardia—Triamcinolone—psoriatic arthritis	0.000538	0.00173	CcSEcCtD
Arformoterol—Mental disorder—Prednisone—psoriatic arthritis	0.000537	0.00173	CcSEcCtD
Arformoterol—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000537	0.00173	CcSEcCtD
Arformoterol—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000534	0.00172	CcSEcCtD
Arformoterol—Malnutrition—Prednisone—psoriatic arthritis	0.000534	0.00172	CcSEcCtD
Arformoterol—Hypertension—Dexamethasone—psoriatic arthritis	0.000529	0.0017	CcSEcCtD
Arformoterol—Hypertension—Betamethasone—psoriatic arthritis	0.000529	0.0017	CcSEcCtD
Arformoterol—Myalgia—Betamethasone—psoriatic arthritis	0.000522	0.00168	CcSEcCtD
Arformoterol—Myalgia—Dexamethasone—psoriatic arthritis	0.000522	0.00168	CcSEcCtD
Arformoterol—Anxiety—Dexamethasone—psoriatic arthritis	0.00052	0.00167	CcSEcCtD
Arformoterol—Anxiety—Betamethasone—psoriatic arthritis	0.00052	0.00167	CcSEcCtD
Arformoterol—Discomfort—Dexamethasone—psoriatic arthritis	0.000515	0.00166	CcSEcCtD
Arformoterol—Discomfort—Betamethasone—psoriatic arthritis	0.000515	0.00166	CcSEcCtD
Arformoterol—Hypotension—Methylprednisolone—psoriatic arthritis	0.000514	0.00165	CcSEcCtD
Arformoterol—Pain—Prednisolone—psoriatic arthritis	0.000513	0.00165	CcSEcCtD
Arformoterol—Pharyngitis—Methotrexate—psoriatic arthritis	0.000508	0.00164	CcSEcCtD
Arformoterol—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000506	0.00163	CcSEcCtD
Arformoterol—Urethral disorder—Methotrexate—psoriatic arthritis	0.000502	0.00162	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000502	0.00162	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000501	0.00161	CcSEcCtD
Arformoterol—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.0005	0.00161	CcSEcCtD
Arformoterol—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.0005	0.00161	CcSEcCtD
Arformoterol—Oedema—Dexamethasone—psoriatic arthritis	0.0005	0.00161	CcSEcCtD
Arformoterol—Oedema—Betamethasone—psoriatic arthritis	0.0005	0.00161	CcSEcCtD
Arformoterol—Insomnia—Triamcinolone—psoriatic arthritis	0.000499	0.0016	CcSEcCtD
Arformoterol—Insomnia—Methylprednisolone—psoriatic arthritis	0.000497	0.0016	CcSEcCtD
Arformoterol—Infection—Dexamethasone—psoriatic arthritis	0.000497	0.0016	CcSEcCtD
Arformoterol—Infection—Betamethasone—psoriatic arthritis	0.000497	0.0016	CcSEcCtD
Arformoterol—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000495	0.00159	CcSEcCtD
Arformoterol—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000494	0.00159	CcSEcCtD
Arformoterol—Visual impairment—Methotrexate—psoriatic arthritis	0.000494	0.00159	CcSEcCtD
Arformoterol—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000491	0.00158	CcSEcCtD
Arformoterol—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00049	0.00158	CcSEcCtD
Arformoterol—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00049	0.00158	CcSEcCtD
Arformoterol—Agitation—Prednisone—psoriatic arthritis	0.00049	0.00158	CcSEcCtD
Arformoterol—Tachycardia—Dexamethasone—psoriatic arthritis	0.000488	0.00157	CcSEcCtD
Arformoterol—Tachycardia—Betamethasone—psoriatic arthritis	0.000488	0.00157	CcSEcCtD
Arformoterol—Angioedema—Prednisone—psoriatic arthritis	0.000488	0.00157	CcSEcCtD
Arformoterol—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000485	0.00156	CcSEcCtD
Arformoterol—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000484	0.00156	CcSEcCtD
Arformoterol—Malaise—Prednisone—psoriatic arthritis	0.000481	0.00155	CcSEcCtD
Arformoterol—Urticaria—Prednisolone—psoriatic arthritis	0.000476	0.00153	CcSEcCtD
Arformoterol—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000475	0.00153	CcSEcCtD
Arformoterol—Fatigue—Triamcinolone—psoriatic arthritis	0.000475	0.00153	CcSEcCtD
Arformoterol—Fatigue—Methylprednisolone—psoriatic arthritis	0.000474	0.00153	CcSEcCtD
Arformoterol—Pain—Triamcinolone—psoriatic arthritis	0.000471	0.00152	CcSEcCtD
Arformoterol—Hypotension—Dexamethasone—psoriatic arthritis	0.000467	0.0015	CcSEcCtD
Arformoterol—Hypotension—Betamethasone—psoriatic arthritis	0.000467	0.0015	CcSEcCtD
Arformoterol—Immune system disorder—Methotrexate—psoriatic arthritis	0.000463	0.00149	CcSEcCtD
Arformoterol—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000462	0.00149	CcSEcCtD
Arformoterol—Hypertension—Prednisone—psoriatic arthritis	0.000461	0.00148	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000456	0.00147	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000456	0.00147	CcSEcCtD
Arformoterol—Arthralgia—Prednisone—psoriatic arthritis	0.000454	0.00146	CcSEcCtD
Arformoterol—Myalgia—Prednisone—psoriatic arthritis	0.000454	0.00146	CcSEcCtD
Arformoterol—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000454	0.00146	CcSEcCtD
Arformoterol—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000453	0.00146	CcSEcCtD
Arformoterol—Anxiety—Prednisone—psoriatic arthritis	0.000453	0.00146	CcSEcCtD
Arformoterol—Insomnia—Dexamethasone—psoriatic arthritis	0.000452	0.00146	CcSEcCtD
Arformoterol—Insomnia—Betamethasone—psoriatic arthritis	0.000452	0.00146	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000451	0.00145	CcSEcCtD
Arformoterol—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00045	0.00145	CcSEcCtD
Arformoterol—Discomfort—Prednisone—psoriatic arthritis	0.000449	0.00145	CcSEcCtD
Arformoterol—Mental disorder—Methotrexate—psoriatic arthritis	0.000449	0.00145	CcSEcCtD
Arformoterol—Malnutrition—Methotrexate—psoriatic arthritis	0.000446	0.00144	CcSEcCtD
Arformoterol—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000442	0.00142	CcSEcCtD
Arformoterol—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00044	0.00142	CcSEcCtD
Arformoterol—Dyspepsia—Betamethasone—psoriatic arthritis	0.00044	0.00142	CcSEcCtD
Arformoterol—Urticaria—Triamcinolone—psoriatic arthritis	0.000438	0.00141	CcSEcCtD
Arformoterol—Urticaria—Methylprednisolone—psoriatic arthritis	0.000437	0.00141	CcSEcCtD
Arformoterol—Dysgeusia—Methotrexate—psoriatic arthritis	0.000437	0.00141	CcSEcCtD
Arformoterol—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000436	0.0014	CcSEcCtD
Arformoterol—Oedema—Prednisone—psoriatic arthritis	0.000436	0.0014	CcSEcCtD
Arformoterol—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000436	0.0014	CcSEcCtD
Arformoterol—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000435	0.0014	CcSEcCtD
Arformoterol—Infection—Prednisone—psoriatic arthritis	0.000433	0.00139	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000432	0.00139	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000432	0.00139	CcSEcCtD
Arformoterol—Back pain—Methotrexate—psoriatic arthritis	0.000431	0.00139	CcSEcCtD
Arformoterol—Fatigue—Betamethasone—psoriatic arthritis	0.000431	0.00139	CcSEcCtD
Arformoterol—Fatigue—Dexamethasone—psoriatic arthritis	0.000431	0.00139	CcSEcCtD
Arformoterol—Pain—Betamethasone—psoriatic arthritis	0.000428	0.00138	CcSEcCtD
Arformoterol—Pain—Dexamethasone—psoriatic arthritis	0.000428	0.00138	CcSEcCtD
Arformoterol—Nervous system disorder—Prednisone—psoriatic arthritis	0.000427	0.00138	CcSEcCtD
Arformoterol—Tachycardia—Prednisone—psoriatic arthritis	0.000425	0.00137	CcSEcCtD
Arformoterol—Skin disorder—Prednisone—psoriatic arthritis	0.000423	0.00136	CcSEcCtD
Arformoterol—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000414	0.00133	CcSEcCtD
Arformoterol—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000412	0.00133	CcSEcCtD
Arformoterol—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000412	0.00133	CcSEcCtD
Arformoterol—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000409	0.00132	CcSEcCtD
Arformoterol—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000409	0.00132	CcSEcCtD
Arformoterol—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000406	0.00131	CcSEcCtD
Arformoterol—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000405	0.0013	CcSEcCtD
Arformoterol—Malaise—Methotrexate—psoriatic arthritis	0.000402	0.00129	CcSEcCtD
Arformoterol—Urticaria—Betamethasone—psoriatic arthritis	0.000397	0.00128	CcSEcCtD
Arformoterol—Urticaria—Dexamethasone—psoriatic arthritis	0.000397	0.00128	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000397	0.00128	CcSEcCtD
Arformoterol—Dizziness—Prednisolone—psoriatic arthritis	0.000396	0.00128	CcSEcCtD
Arformoterol—Asthenia—Triamcinolone—psoriatic arthritis	0.000395	0.00127	CcSEcCtD
Arformoterol—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000395	0.00127	CcSEcCtD
Arformoterol—Abdominal pain—Betamethasone—psoriatic arthritis	0.000395	0.00127	CcSEcCtD
Arformoterol—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000395	0.00127	CcSEcCtD
Arformoterol—Body temperature increased—Betamethasone—psoriatic arthritis	0.000395	0.00127	CcSEcCtD
Arformoterol—Asthenia—Methylprednisolone—psoriatic arthritis	0.000395	0.00127	CcSEcCtD
Arformoterol—Insomnia—Prednisone—psoriatic arthritis	0.000394	0.00127	CcSEcCtD
Arformoterol—Pruritus—Triamcinolone—psoriatic arthritis	0.00039	0.00126	CcSEcCtD
Arformoterol—Cough—Methotrexate—psoriatic arthritis	0.000389	0.00125	CcSEcCtD
Arformoterol—Pruritus—Methylprednisolone—psoriatic arthritis	0.000389	0.00125	CcSEcCtD
Arformoterol—Dyspepsia—Prednisone—psoriatic arthritis	0.000383	0.00123	CcSEcCtD
Arformoterol—Myalgia—Methotrexate—psoriatic arthritis	0.00038	0.00122	CcSEcCtD
Arformoterol—Chest pain—Methotrexate—psoriatic arthritis	0.00038	0.00122	CcSEcCtD
Arformoterol—Arthralgia—Methotrexate—psoriatic arthritis	0.00038	0.00122	CcSEcCtD
Arformoterol—Rash—Prednisolone—psoriatic arthritis	0.000378	0.00122	CcSEcCtD
Arformoterol—Dermatitis—Prednisolone—psoriatic arthritis	0.000378	0.00122	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000377	0.00121	CcSEcCtD
Arformoterol—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000376	0.00121	CcSEcCtD
Arformoterol—Fatigue—Prednisone—psoriatic arthritis	0.000375	0.00121	CcSEcCtD
Arformoterol—Headache—Prednisolone—psoriatic arthritis	0.000375	0.00121	CcSEcCtD
Arformoterol—Discomfort—Methotrexate—psoriatic arthritis	0.000375	0.00121	CcSEcCtD
Arformoterol—Constipation—Prednisone—psoriatic arthritis	0.000372	0.0012	CcSEcCtD
Arformoterol—Dizziness—Triamcinolone—psoriatic arthritis	0.000364	0.00117	CcSEcCtD
Arformoterol—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000364	0.00117	CcSEcCtD
Arformoterol—Dizziness—Methylprednisolone—psoriatic arthritis	0.000364	0.00117	CcSEcCtD
Arformoterol—Infection—Methotrexate—psoriatic arthritis	0.000362	0.00116	CcSEcCtD
Arformoterol—Feeling abnormal—Prednisone—psoriatic arthritis	0.000359	0.00116	CcSEcCtD
Arformoterol—Asthenia—Betamethasone—psoriatic arthritis	0.000359	0.00116	CcSEcCtD
Arformoterol—Asthenia—Dexamethasone—psoriatic arthritis	0.000359	0.00116	CcSEcCtD
Arformoterol—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000357	0.00115	CcSEcCtD
Arformoterol—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000356	0.00115	CcSEcCtD
Arformoterol—Nausea—Prednisolone—psoriatic arthritis	0.000356	0.00115	CcSEcCtD
Arformoterol—Pruritus—Betamethasone—psoriatic arthritis	0.000354	0.00114	CcSEcCtD
Arformoterol—Pruritus—Dexamethasone—psoriatic arthritis	0.000354	0.00114	CcSEcCtD
Arformoterol—Skin disorder—Methotrexate—psoriatic arthritis	0.000354	0.00114	CcSEcCtD
Arformoterol—Vomiting—Triamcinolone—psoriatic arthritis	0.00035	0.00113	CcSEcCtD
Arformoterol—Vomiting—Methylprednisolone—psoriatic arthritis	0.00035	0.00113	CcSEcCtD
Arformoterol—Rash—Triamcinolone—psoriatic arthritis	0.000348	0.00112	CcSEcCtD
Arformoterol—Dermatitis—Triamcinolone—psoriatic arthritis	0.000347	0.00112	CcSEcCtD
Arformoterol—Rash—Methylprednisolone—psoriatic arthritis	0.000347	0.00112	CcSEcCtD
Arformoterol—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000346	0.00112	CcSEcCtD
Arformoterol—Urticaria—Prednisone—psoriatic arthritis	0.000346	0.00111	CcSEcCtD
Arformoterol—Headache—Triamcinolone—psoriatic arthritis	0.000345	0.00111	CcSEcCtD
Arformoterol—Headache—Methylprednisolone—psoriatic arthritis	0.000345	0.00111	CcSEcCtD
Arformoterol—Body temperature increased—Prednisone—psoriatic arthritis	0.000344	0.00111	CcSEcCtD
Arformoterol—Abdominal pain—Prednisone—psoriatic arthritis	0.000344	0.00111	CcSEcCtD
Arformoterol—Diarrhoea—Betamethasone—psoriatic arthritis	0.000342	0.0011	CcSEcCtD
Arformoterol—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000342	0.0011	CcSEcCtD
Arformoterol—Hypotension—Methotrexate—psoriatic arthritis	0.00034	0.00109	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000332	0.00107	CcSEcCtD
Arformoterol—Dizziness—Betamethasone—psoriatic arthritis	0.000331	0.00106	CcSEcCtD
Arformoterol—Dizziness—Dexamethasone—psoriatic arthritis	0.000331	0.00106	CcSEcCtD
Arformoterol—Insomnia—Methotrexate—psoriatic arthritis	0.000329	0.00106	CcSEcCtD
Arformoterol—Nausea—Triamcinolone—psoriatic arthritis	0.000327	0.00105	CcSEcCtD
Arformoterol—Nausea—Methylprednisolone—psoriatic arthritis	0.000327	0.00105	CcSEcCtD
Arformoterol—Dyspnoea—Methotrexate—psoriatic arthritis	0.000325	0.00104	CcSEcCtD
Arformoterol—Somnolence—Methotrexate—psoriatic arthritis	0.000324	0.00104	CcSEcCtD
Arformoterol—Hypersensitivity—Prednisone—psoriatic arthritis	0.000321	0.00103	CcSEcCtD
Arformoterol—Dyspepsia—Methotrexate—psoriatic arthritis	0.00032	0.00103	CcSEcCtD
Arformoterol—Vomiting—Betamethasone—psoriatic arthritis	0.000318	0.00102	CcSEcCtD
Arformoterol—Vomiting—Dexamethasone—psoriatic arthritis	0.000318	0.00102	CcSEcCtD
Arformoterol—Rash—Dexamethasone—psoriatic arthritis	0.000315	0.00102	CcSEcCtD
Arformoterol—Rash—Betamethasone—psoriatic arthritis	0.000315	0.00102	CcSEcCtD
Arformoterol—Dermatitis—Betamethasone—psoriatic arthritis	0.000315	0.00101	CcSEcCtD
Arformoterol—Dermatitis—Dexamethasone—psoriatic arthritis	0.000315	0.00101	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000314	0.00101	CcSEcCtD
Arformoterol—Fatigue—Methotrexate—psoriatic arthritis	0.000314	0.00101	CcSEcCtD
Arformoterol—Headache—Dexamethasone—psoriatic arthritis	0.000313	0.00101	CcSEcCtD
Arformoterol—Headache—Betamethasone—psoriatic arthritis	0.000313	0.00101	CcSEcCtD
Arformoterol—Asthenia—Prednisone—psoriatic arthritis	0.000312	0.00101	CcSEcCtD
Arformoterol—Pain—Methotrexate—psoriatic arthritis	0.000311	0.001	CcSEcCtD
Arformoterol—Pruritus—Prednisone—psoriatic arthritis	0.000308	0.000992	CcSEcCtD
Arformoterol—Feeling abnormal—Methotrexate—psoriatic arthritis	0.0003	0.000966	CcSEcCtD
Arformoterol—Diarrhoea—Prednisone—psoriatic arthritis	0.000298	0.000959	CcSEcCtD
Arformoterol—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000298	0.000958	CcSEcCtD
Arformoterol—Nausea—Betamethasone—psoriatic arthritis	0.000297	0.000956	CcSEcCtD
Arformoterol—Nausea—Dexamethasone—psoriatic arthritis	0.000297	0.000956	CcSEcCtD
Arformoterol—Urticaria—Methotrexate—psoriatic arthritis	0.000289	0.000931	CcSEcCtD
Arformoterol—Dizziness—Prednisone—psoriatic arthritis	0.000288	0.000927	CcSEcCtD
Arformoterol—Abdominal pain—Methotrexate—psoriatic arthritis	0.000288	0.000926	CcSEcCtD
Arformoterol—Body temperature increased—Methotrexate—psoriatic arthritis	0.000288	0.000926	CcSEcCtD
Arformoterol—Vomiting—Prednisone—psoriatic arthritis	0.000277	0.000892	CcSEcCtD
Arformoterol—Rash—Prednisone—psoriatic arthritis	0.000275	0.000884	CcSEcCtD
Arformoterol—Dermatitis—Prednisone—psoriatic arthritis	0.000274	0.000883	CcSEcCtD
Arformoterol—Headache—Prednisone—psoriatic arthritis	0.000273	0.000878	CcSEcCtD
Arformoterol—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000268	0.000863	CcSEcCtD
Arformoterol—Asthenia—Methotrexate—psoriatic arthritis	0.000261	0.000841	CcSEcCtD
Arformoterol—Nausea—Prednisone—psoriatic arthritis	0.000259	0.000833	CcSEcCtD
Arformoterol—Pruritus—Methotrexate—psoriatic arthritis	0.000258	0.000829	CcSEcCtD
Arformoterol—Diarrhoea—Methotrexate—psoriatic arthritis	0.000249	0.000802	CcSEcCtD
Arformoterol—Dizziness—Methotrexate—psoriatic arthritis	0.000241	0.000775	CcSEcCtD
Arformoterol—Vomiting—Methotrexate—psoriatic arthritis	0.000231	0.000745	CcSEcCtD
Arformoterol—Rash—Methotrexate—psoriatic arthritis	0.000229	0.000739	CcSEcCtD
Arformoterol—Dermatitis—Methotrexate—psoriatic arthritis	0.000229	0.000738	CcSEcCtD
Arformoterol—Headache—Methotrexate—psoriatic arthritis	0.000228	0.000734	CcSEcCtD
Arformoterol—Nausea—Methotrexate—psoriatic arthritis	0.000216	0.000696	CcSEcCtD
